The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin

BACKGROUND: Fibrosing diseases are a leading cause of morbidity and mortality worldwide and, therefore, there is a need for safe and effective antifibrotic therapies. Adenosine, generated extracellularly by the dephosphorylation of adenine nucleotides, ligates specific receptors which play a critica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Feig, Jessica L., Mediero, Aranzazu, Corciulo, Carmen, Liu, Hailing, Zhang, Jin, Perez-Aso, Miguel, Picard, Laura, Wilder, Tuere, Cronstein, Bruce
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5690602/
https://ncbi.nlm.nih.gov/pubmed/29145453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados